Pharm Exec15h
FDA Grants Fast Track Designation to Adicet Bio’s CAR T-cell Therapy for Systemic Lupus Erythematosus
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
Adicet Bio granted fast track designation for ADI-001 by FDA
Adicet Bio (ACET) announced the FDA has granted fast track designation to ADI-001 for the potential treatment of adult patients with refractory ...
Adicet Bio Gets Fast Track Designation For ADI-001 In Refractory Systemic Lupus Erythematosus
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Adelaide Now6d
Health Check: Alterity angles for fast-track FDA approval after positive trial results tackling Parkinson’s-like disorder
Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy treatment. Alterity shares soared up to 112% this morning after the company ...
Cure Today3d
ITM-11 Meets Phase 3 Trial Primary End Point of PFS in GEP-NETs
Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...
Recycling Today11hOpinion
Commentary: NextLoopp offers a path to using food-grade recycled polypropylene in food-contact packaging
NextLoopp Americas aims to mobilize U.S.-based organizations to participate in closing the loop on the most prolific fraction ...